DERM
Journey Medical Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.86
−0.51%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
39.8x
EV/EBITDA
119.9x
Market Cap
$221.84M
MomentumView details →
1D Return
−0.51%
YTD Return
+2.20%
RSI (14)
66.6
ValuationView details →
P/E (Fwd)
39.8x
EV/EBITDA
119.9x
Market Cap
$221.84M
RSI (14)
66.6
MomentumView details →
1D Return
−0.51%
YTD Return
+2.20%
SummaryUpdated Jun 1, 2026
Journey Medical Corporation (NASDAQ:DERM) is a specialty pharmaceutical company founded in 2014 and headquartered in Scottsdale, Arizona. Originally incorporated as Coronado Dermatology, Inc., the company went public in November 2021 and focuses exclusively on developing and commercializing prescription treatments for dermatological conditions. Journey Medical has built a portfolio of FDA-approved dermatology products targeting conditions such as severe acne, hyperhidrosis (excessive sweating), rosacea, and various topical skin infections, serving the specialized needs of dermatologists and their patients across the United States.
Similar companies
Latest newsMore news →
Starbucks opened its first Starbucks Reserve store in South India, located in Hyderabad, as the sixth Reserve outlet in India.15d agoJourney Medical Corp reported Q2 2026 revenue of $18.5 million, up 23% year-over-year, with a GAAP net loss of $0.3 million and non-GAAP adjusted EBITDA of $2.862 million.24d ago